Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.
You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.
Other companies in Coeptis Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), ABVC BioPharma (NASDAQ:ABVC) and Viracta Therapeutics (NASDAQ:VIRX).
Coeptis Therapeutics has a consensus price target of $5.67.
The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $0.205 last updated October 31, 2024 at 8:15 AM EDT.
There are no upcoming dividends for Coeptis Therapeutics.
Coeptis Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Coeptis Therapeutics.
Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.